4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-011554
President sold 30,000 shares at an average $65.61 ($1,968,432)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
RUBINSTEIN JULIE · President
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-12 | Exercise or conversion : show line 1 in the form | +15,000 | $6.55 | $98,250 | 15,000 | D |
| 2021-02-12 | Sale : show line 2 in the form | −1,949 | $64.53 | $125,769 | 13,050 | D |
| 2021-02-12 | Sale : show line 3 in the form | −3,130 | $65.55 | $205,172 | 9,921 | D |
| 2021-02-12 | Sale : show line 4 in the form | −9,621 | $66.38 | $638,642 | 300 | D |
| 2021-02-12 | Sale : show line 5 in the form | −300 | $67.00 | $20,100 | 0 | D |
| 2021-02-16 | Exercise or conversion : show line 6 in the form | +15,000 | $6.55 | $98,250 | 15,000 | D |
| 2021-02-16 | Sale : show line 7 in the form | −1,699 | $64.78 | $110,061 | 13,301 | D |
| 2021-02-16 | Sale : show line 8 in the form | −13,301 | $65.31 | $868,688 | 0 | D |
| Open-market sales · 30,000 sh · avg $65.61 · $1,968,432 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-12 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −15,000 | 345,000 | D |
| 2021-02-16 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −15,000 | 330,000 | D |
Loading xslF345X03/doc4.xml…